Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.

Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page
- Check3 days agoChange DetectedRevision labels updated from v3.3.3 to v3.3.4; this is a minor backend/version update and does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe Locations section was updated to reflect study sites by state, and the page revision was bumped to v3.3.3.SummaryDifference1%

- Check46 days agoChange DetectedSite revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange Detected- Revision: v3.3.1 was added. - Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check60 days agoChange DetectedThe government funding status banner was removed. All study details, eligibility criteria, locations, and outcomes remain unchanged.SummaryDifference0.3%

- Check75 days agoChange DetectedNon-significant changes include metadata updates (e.g., last update date, results submission dates) with no changes to core study details, eligibility criteria, arms, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.